Enovis (ENOV) Income from Continuing Operations (2010 - 2026)

Enovis (ENOV) reported Income from Continuing Operations of 8411000.0 for Q2 2026, up 84.87% year-over-year from 4549760.87 in Q2 2025, and up 98.38% quarter-over-quarter from 518803000.0 in Q4 2025.

Enovis (ENOV) Income from Continuing Operations (2010 - 2026) Analysis & Trends

Enovis (ENOV) has 17 years of Income from Continuing Operations data on file, last reported at 8411000.0 in Q2 2026.

  • Income from Continuing Operations for Q2 2026 came in at 8411000.0, up 84.87% year-over-year; the trailing twelve-month figure through Apr 2026 was 1134542000.0 (down 39.87% YoY), and the FY2025 annual result was 1181711000.0, down 42.82% from the prior year.
  • Income from Continuing Operations improved to 8411000.0 in Q2 2026 per ENOV's latest filing, from 518803000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 120600000.0 in Q3 2022 and troughed at 703626000.0 in Q4 2024.
  • A 5-year average of 124097470.59 and a median of 36455000.0 in 2025 frame the typical range for Income from Continuing Operations.
  • The sharpest annual moves came in 2022 and 2024: Income from Continuing Operations jumped 386.39% in 2022, then tumbled 23034.35% in 2024.
  • A 5-year view of Income from Continuing Operations shows it stood at 54840000.0 in 2022, then surged by 105.59% to 3068000.0 in 2023, then plunged by 23034.35% to 703626000.0 in 2024, then grew by 26.27% to 518803000.0 in 2025, then jumped by 98.38% to 8411000.0 in 2026.
  • Business Quant data shows ENOV's Income from Continuing Operations at 8411000.0 in Q2 2026, 518803000.0 in Q4 2025, and 570873000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 1.08 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 745.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 380.70 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 273.95 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 199.50 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 411.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 220.30 Mn
10 Enovis 1.26 Bn 1.23 Bn 365.49 Mn -8.41 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 -8.41 Mn
Dec 31, 2025 -518.80 Mn
Oct 3, 2025 -570.87 Mn
Jul 4, 2025 -36.46 Mn
Apr 4, 2025 -55.58 Mn
Dec 31, 2024 -703.63 Mn
Sep 27, 2024 -33.51 Mn
Jun 28, 2024 -18.44 Mn
Mar 29, 2024 -71.84 Mn
Dec 31, 2023 3.07 Mn
Sep 29, 2023 -19.45 Mn
Jun 30, 2023 -14.61 Mn
Mar 31, 2023 -22.85 Mn
Dec 31, 2022 -54.84 Mn
Sep 30, 2022 -65.95 Mn
Jul 1, 2022 120.60 Mn
Apr 1, 2022 -38.09 Mn
Dec 31, 2021 -14.75 Mn
Oct 1, 2021 -13.58 Mn
Jul 2, 2021 -42.11 Mn